Characteristic | All Patients (N = 715) | CRG (N = 295) | IRG (N = 420) |
---|---|---|---|
Baseline (pre-DFK) WI-NRS score, mean (SD) | 8.5 (1.7) | 8.5 (1.8) | 8.5 (1.6) |
12-week WI-NRS score available, n (%) | 156 (21.8) | 84 (28.5) | 72 (17.1) |
DFK dose, mL, mean (SD)a | 0.81 (0.24) | 0.83 (0.25) | 0.79 (0.24) |
Female, n (%) | 345 (48.3) | 124 (42.0) | 221 (52.6) |
Black, n (%) | 285 (39.9) | 113 (38.3) | 172 (41.0) |
Hispanic, n (%) | 68 (9.5) | 29 (9.8) | 39 (9.3) |
Age at first DFK administration, years, mean (SD) | 64.7 (13.0) | 66.1 (12.9) | 63.8 (13.1) |
Vintage at first DFK administration, years, mean (SD) | 4.8 (4.5) | 4.4 (4.2) | 5.2 (4.6) |
Primary insurance, n (%) | |||
Medicare | 319 (44.6) | 129 (43.7) | 190 (45.2) |
Commercial | 5 (0.7) | 2 (0.7) | 3 (0.7) |
Managed Medicare | 388 (54.3) | 162 (54.9) | 226 (53.8) |
Exchange | 2 (0.3) | 1 (0.3) | 1 (0.2) |
Self | 1 (0.1) | 1 (0.3) | 0 (0.0) |